Saniona AB (CHIX:SANIOS) Other Current Liabilities: kr25.5 Mil (As of Mar. 2026)


CHIX:SANIOS Saniona AB CHIX:SANIOS
65 GF Score
Price kr12.75
GF Value kr26.65
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Saniona AB Other Current Liabilities?

Saniona AB CHIX:SANIOS 65 Other Current Liabilities is kr25.5 Mil as of Mar. 2026. GuruFocus rates CHIX:SANIOS with a GF Score™ of 65/100 and a GF Value™ of kr26.65 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Saniona AB's other current liabilities for the quarter that ended in Mar. 2026 was kr25.5 Mil.

Saniona AB's quarterly other current liabilities declined from Sep. 2025 (kr27.2 Mil) to Dec. 2025 (kr20.8 Mil) but then increased from Dec. 2025 (kr20.8 Mil) to Mar. 2026 (kr25.5 Mil).

Saniona AB's annual other current liabilities increased from Dec. 2023 (kr2.9 Mil) to Dec. 2024 (kr57.1 Mil) but then declined from Dec. 2024 (kr57.1 Mil) to Dec. 2025 (kr20.8 Mil).

Saniona AB Other Current Liabilities Related Terms

Saniona AB Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Saniona AB's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Saniona AB Other Current Liabilities Chart

Saniona AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.73 2.86 2.90 57.05 20.82

Saniona AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 63.88 34.01 27.20 20.82 25.46
CHIX:SANIOS
65GF Score
Saniona AB CHIX:SANIOS
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Saniona AB Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of kr25.5 Mil mean?
Saniona AB (CHIX:SANIOS) has a Other Current Liabilities of kr25.5 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Saniona AB.
Is Saniona AB's Other Current Liabilities too high?
Saniona AB's current Other Current Liabilities is kr25.5 Mil. Overall, Saniona AB has a GF Score™ of 65/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Saniona AB's Other Current Liabilities compare to VRTX and REGN?
Saniona AB's Other Current Liabilities of kr25.5 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Saniona AB. Saniona AB's current Other Current Liabilities is kr25.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saniona AB stock overvalued right now?
Based on GuruFocus' analysis, Saniona AB (CHIX:SANIOS) is currently considered Significantly Undervalued. The stock's GF Value™ is kr26.65, compared to a current price of kr12.75 — trading 52.2% below its estimated fair value. The current Other Current Liabilities is kr25.5 Mil. Saniona AB's overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Saniona AB (CHIX:SANIOS), the current Other Current Liabilities is kr25.5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Saniona AB (CHIX:SANIOS) Overvalued in 2026?

Based on GuruFocus' analysis, Saniona AB stock appears to be undervalued. The current stock price of kr12.75 is trading 52.2% below its estimated GF Value™ of kr26.65. GuruFocus considers Saniona AB to be Significantly Undervalued.

Key valuation signals for CHIX:SANIOS:

  • Other Current Liabilities: kr25.5 Mil
  • GF Value™: kr26.65 vs. price of kr12.75 (52.2% below fair value)
  • GF Score™: 65/100 with 3 warning signs

No single metric tells the full story. See the CHIX:SANIOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Saniona AB Business Description

Address Murervangen 42, Glostrup, DNK, DK-2600
Saniona AB researches and develops drugs for the treatment of diseases of the central nervous system, autoimmune diseases, metabolic diseases, and the treatment of pain. It develops a technology platform that enables the investigation of all types of ion channel drug targets. Its research is focused on GABAA receptors, nicotinic acetylcholine receptors, and potassium channels. The company product pipeline includes Tesomet, SAN711, Tesofensine, SAN903, and SAN2219. Geographically, it operates in USA, Sweden, Germany, Denmark, and United Kingdom, out of which it derives maximum revenue from USA.
65GF Score

Get the complete analysis for CHIX:SANIOS

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr12.75
Price
kr26.65
GF Value